BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3678329)

  • 1. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical approaches to optimization of cancer chemotherapy.
    Zietz S; Nicolini C
    Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating and designing cancer chemotherapy treatment using mathematical models.
    Birkhead BG; Gregory WM; Slevin ML; Harvey VJ
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):3-8. PubMed ID: 3956557
    [No Abstract]   [Full Text] [Related]  

  • 5. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An example of the effects of drug resistance on the optimal schedule for a single drug in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1995; 12(1):55-69. PubMed ID: 7594878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modelling: Forecasting cancer.
    Gammon K
    Nature; 2012 Nov; 491(7425):S66-7. PubMed ID: 23320294
    [No Abstract]   [Full Text] [Related]  

  • 11. Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response.
    Rodrigues DS; de Arruda Mancera PF
    Math Biosci Eng; 2013 Feb; 10(1):221-34. PubMed ID: 23311370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamics of cell proliferation.
    Moxnes JF; Haux J; Hausken K
    Med Hypotheses; 2004; 62(4):556-63. PubMed ID: 15050107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Mar; 59(2):205-32. PubMed ID: 9116600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).
    Skipper HE
    Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
    Acharya RS; Sundareshan MK
    Int J Biomed Comput; 1984; 15(2):139-50. PubMed ID: 6724730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
    Nani FK; Oğuztöreli MN
    IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model.
    Powathil GG; Gordon KE; Hill LA; Chaplain MA
    J Theor Biol; 2012 Sep; 308():1-19. PubMed ID: 22659352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive cytotoxic chemotherapy.
    Bagshawe KD
    J R Coll Physicians Lond; 1971 Jan; 5(2):157-66. PubMed ID: 4131399
    [No Abstract]   [Full Text] [Related]  

  • 20. Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.
    Usher JR; Henderson D
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):99-126. PubMed ID: 8671582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.